Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
1.
Value Health Reg Issues ; 24: 240-246, 2021 May.
Article in English | MEDLINE | ID: covidwho-1199117

ABSTRACT

OBJECTIVES: Vaccines are recognized as the most effective strategy for long-term prevention of coronavirus disease 2019 (COVID-19) because they can reduce morbidity and mortality. The purpose of the present study was to evaluate willingness to pay (WTP) for a future COVID-19 vaccination among young adults in Southern Vietnam. METHODS: A cross-sectional, descriptive, and analytic study was undertaken with data collected from a community-based survey in southern Vietnam for 2 weeks in May 2020. The contingent valuation method was used to estimate WTP for COVID-19 vaccine. The average amount that respondents were willing to pay for the vaccine was US$ 85.9 2 ± 69.01. RESULTS: We also found the differences in WTP according to sex, living area, monthly income, and the level of self-rated risk of COVID-19. CONCLUSION: Our findings possibly contribute to the implementation of a pricing policy when the COVID-19 vaccine is introduced in Vietnam.


Subject(s)
COVID-19 Vaccines/economics , Health Expenditures/standards , Immunization/economics , Patients/psychology , Adolescent , Adult , COVID-19 Vaccines/therapeutic use , Cross-Sectional Studies , Female , Health Care Costs/standards , Health Care Costs/statistics & numerical data , Health Expenditures/statistics & numerical data , Humans , Immunization/methods , Male , Middle Aged , Patients/statistics & numerical data , Vietnam
2.
Am J Trop Med Hyg ; 104(2): 436-440, 2020 Dec 02.
Article in English | MEDLINE | ID: covidwho-955246

ABSTRACT

The COVID-19 pandemic has created an unprecedented health crisis and a substantial socioeconomic impact. It also affects tuberculosis (TB) control severely worldwide. Interruptions of many TB control programs because of the COVID-19 pandemic could result in significant setbacks. One of the targets that can be affected is the WHO's End TB Strategy goal to eliminate catastrophic costs of TB-affected households by 2030. Disruptions to TB programs and healthcare services due to COVID-19 could potentially prolong diagnostic delays and worsen TB treatment adherence and outcomes. The economic recession caused by the pandemic could significantly impact household financial capacity because of the reduction of income and the rise in unemployment rates. All of these factors increase the risk of TB incidence and the gravity of economic impact on TB-affected households, and hamper efforts to eliminate catastrophic costs and control TB. Therefore, efforts to eliminate the incidence of TB-affected households facing catastrophic costs will be very challenging. Because financial constraint plays a significant role in TB control, the improvement of health and social protection systems is critical. Even before the pandemic, many TB-high-burden countries (HBCs) lacked robust health and social protection systems. These challenges highlight the substantial need for a more robust engagement of patients and civil society organizations and international support in addressing the consequences of COVID-19 on the control of TB.


Subject(s)
COVID-19/economics , Health Care Costs/statistics & numerical data , Tuberculosis/economics , COVID-19/epidemiology , Family Characteristics , Health Care Costs/standards , Health Care Costs/trends , Humans , Incidence , Income , SARS-CoV-2 , Tuberculosis/epidemiology , Tuberculosis/prevention & control
3.
Ann Vasc Surg ; 70: 306-313, 2021 Jan.
Article in English | MEDLINE | ID: covidwho-739733

ABSTRACT

BACKGROUND: The situation of coronavirus disease 2019 (COVID-19) pandemic in the Indian subcontinent is worsening. In Bangladesh, rate of new infection has been on the rise despite limited testing facility. Constraint of resources in the health care sector makes the fight against COVID-19 more challenging for a developing country like Bangladesh. Vascular surgeons find themselves in a precarious situation while delivering professional services during this crisis. With the limited number of dedicated vascular surgeons in Bangladesh, it is important to safeguard these professionals without compromising emergency vascular care services in the long term. To this end, we at the National Institute of Cardiovascular Diseases and Hospital, Dhaka, have developed a working guideline for our vascular surgeons to follow during the COVID-19 pandemic. The guideline takes into account high vascular work volume against limited resources in the country. METHODS: A total of 307 emergency vascular patients were dealt with in the first 4 COVID-19 months (March through June 2020) according to the working guideline, and the results were compared with the 4 pre-COVID-19 months. Vascular trauma, dialysis access complications, and chronic limb-threatening ischemia formed the main bulk of the patient population. Vascular health care workers were regularly screened for COVID-19 infection. RESULTS: There was a 38% decrease in the number of patients in the COVID-19 period. Treatment outcome in COVID-19 months were comparable with that in the pre-COVID-19 months except that limb loss in the chronic limb-threatening ischemia patients was higher. COVID-19 infection among the vascular health care professionals was low. CONCLUSIONS: Vascular surgery practice guidelines customized for the high work volume and limited resources of the National Institute of Cardiovascular Diseases and Hospital, Dhaka were effective in delivering emergency care during COVID-19 pandemic, ensuring safety of the caregivers. Despite the fact that similar guidelines exist in different parts of the world, we believe that the present one is still relevant on the premises of a deepening COVID-19 crisis in a developing country like Bangladesh.


Subject(s)
COVID-19 , Developing Countries , Hospitals, High-Volume/standards , Outcome and Process Assessment, Health Care/standards , Practice Patterns, Physicians'/standards , Surgeons/standards , Vascular Surgical Procedures/standards , Workload/standards , Bangladesh , Developing Countries/economics , Health Care Costs/standards , Humans , Outcome and Process Assessment, Health Care/economics , Practice Patterns, Physicians'/economics , Surgeons/economics , Time Factors , Treatment Outcome , Vascular Surgical Procedures/economics , Workload/economics
SELECTION OF CITATIONS
SEARCH DETAIL